top of page

Related Posts

See All
Written Question: Terms for Rare Cancers Lead

Lord Moylan: To ask His Majesty's Government whether they intend that the national specialty lead for rare cancers, to be appointed under the Rare Cancers Act 2026, is to be a full-time, appropriately

 
 
 

Comments

bottom of page